Genomics Biosci &Tech Co Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomics Biosci &Tech Co Ltd with three other
companies in this sector in Taiwan:
Medigen Biotechnology Corporation
sales of 407.31 million Taiwanese Dollars [US$13.35 million]
of which 83%
was Drug Discovery),
Welgene Biotech Co Ltd
(384.43 million Taiwanese Dollars [US$12.60 million]
Sofiva Genomics Co Ltd
(459.40 million Taiwanese Dollars [US$15.05 million]
of which 96%
was Testing service-Taiwan).
During the year ended December of 2018, sales at
Genomics Biosci &Tech Co Ltd were 438.69 million Taiwanese Dollars (US$14.38 million).
decrease of 0.2%
versus 2017, when the company's sales were 439.53 million Taiwanese Dollars.